Drug intelligence / Profile preview

benfotiamine + pyridoxine + cyanocobalamin

Development stage
Unknown
Lead developer
Alfresa
Modality
Small Molecules
Administration
Oral, Intramuscular
01

Overview

**Benfotiamine + pyridoxine + cyanocobalamin** is a combination drug composed of three B vitamins: benfotiamine (a fat-soluble derivative of thiamine/Vitamin B1), pyridoxine (Vitamin B6), and cyanocobalamin (Vitamin B12). This combination is primarily used to treat or prevent deficiencies in these vitamins, particularly in patients with nutritional deficiencies, neuropathy, or anemia. Mechanistically, benfotiamine supports nervous system health and glucose metabolism as an active form of thiamine[5]. Pyridoxine is essential for amino acid metabolism and nerve function, and cyanocobalamin is necessary for red blood cell formation and myelin synthesis. The combination also demonstrates synergetic effects including anti-inflammatory, antioxidant, and neuroprotective properties; it may potentiate analgesia via modulation of sodium channels, P2X receptors, adenosine receptors, and various neurotransmitter pathways[3][4]. It has been studied for use both alone and as an adjunct to nonsteroidal anti-inflammatory drugs (NSAIDs) for the management of neuropathic pain, low back pain, and other conditions involving nerve damage[3][4].

02

Targets

P2RX1 (Purinergic receptor P2X 1)ADOR (Adenosine receptors)MMUT (Methylmalonyl-coenzyme A mutase)THTR (Thiamine transporter 1)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on benfotiamine + pyridoxine + cyanocobalamin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on benfotiamine + pyridoxine + cyanocobalamin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call